Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Palliative Care
•
Critical Care
•
Hospital Medicine
When do you recommend starting a continuous opioid infusion for symptom control at the end of life?
Related Questions
Do you prefer scopolamine patches, glycopyrrolate, or other treatment regimens to manage oral secretions at the end of life?
At what point should you consider deactivating ICDs or implanted pacemakers in patients nearing the end of life but not imminently dying?
Under what circumstances do you recommend POCUS guidance for lumbar puncture?
Does the use of NIV for pre-oxygenation delay the time to intubation?
When can we consider deferring an insulin drip in patients with hypertriglyceridemia-induced pancreatitis?
What recommendations do you have regarding the use of dronabinol to prevent cannabis withdrawal in an inpatient medical or psychiatric setting?
Would you recommend starting tolvaptan at 7.5 mg per day, which is half the typical starting dose, to reduce the risk of overcorrection in an inpatient with SIADH and a serum sodium level of 122 mEq/L?
Is the adage “If GCS <8, intubate” still relevant for non-TBI patients?
In a patient with acute stroke/ICH/SDH/hyperammonemia at risk for rebound edema with new onset renal failure, do you prefer CRRT versus low and slow HD? How frequently do you monitor osmolarity?
Do you recommend careful correction of serum sodium to avoid osmotic demyelination syndrome in patients who are found to have isoosmolar hyponatremia in the setting of an elevated BUN level?
